Jiang, T., Wang, G., Liu, Y., Feng, L., Wang, M., Liu, J., . . . Ouyang, L. (2021). Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. Acta Pharm Sin B.
Chicago-tyylinen lähdeviittausJiang, Tingting, Guan Wang, Yao Liu, Lu Feng, Meng Wang, Jie Liu, Yi Chen, ja Liang Ouyang. "Development of Small-molecule Tropomyosin Receptor Kinase (TRK) Inhibitors for NTRK Fusion Cancers." Acta Pharm Sin B 2021.
MLA-viiteJiang, Tingting, et al. "Development of Small-molecule Tropomyosin Receptor Kinase (TRK) Inhibitors for NTRK Fusion Cancers." Acta Pharm Sin B 2021.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.